SGPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.50379996922379E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.47359999758123E-08 |
Normal-vs-Stage2 |
5.36149999952329E-08 |
Normal-vs-Stage3 |
5.80890002765955E-09 |
Normal-vs-Stage4 |
1.8768999999752E-06 |
Stage1-vs-Stage2 |
6.956600E-01 |
Stage1-vs-Stage3 |
4.238000E-01 |
Stage1-vs-Stage4 |
3.693400E-01 |
Stage2-vs-Stage3 |
8.413200E-01 |
Stage2-vs-Stage4 |
3.372800E-01 |
Stage3-vs-Stage4 |
1.751160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.97170004954262E-09 |
Normal-vs-AfricanAmerican |
1.93290000005675E-07 |
Normal-vs-Asian |
1.833510E-02 |
Caucasian-vs-AfricanAmerican |
9.519800E-01 |
Caucasian-vs-Asian |
2.763400E-01 |
AfricanAmerican-vs-Asian |
2.526600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.65980004687805E-09 |
Normal-vs-Female |
2.60660000028778E-07 |
Male-vs-Female |
4.084000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.17510000000343E-05 |
Normal-vs-Age(41-60Yrs) |
1.17699999746534E-08 |
Normal-vs-Age(61-80Yrs) |
2.78199999703688E-08 |
Normal-vs-Age(81-100Yrs) |
1.16329999999554E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.175400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.017200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.116000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.143400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.527400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.852000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.209550E-04 |
Normal-vs-Grade 2 |
5.96030003130466E-09 |
Normal-vs-Grade 3 |
1.09469999731715E-08 |
Normal-vs-Grade 4 |
3.79380000000706E-05 |
Grade 1-vs-Grade 2 |
7.825800E-01 |
Grade 1-vs-Grade 3 |
8.329200E-01 |
Grade 1-vs-Grade 4 |
5.935400E-01 |
Grade 2-vs-Grade 3 |
9.652400E-01 |
Grade 2-vs-Grade 4 |
1.041200E-01 |
Grade 3-vs-Grade 4 |
1.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.29370003388152E-09 |
Normal-vs-ccB subtype |
1.39770000018302E-07 |
ccA subtype-vs-ccB subtype |
2.804600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.84329999836686E-08 |
Normal-vs-N1 |
1.790950E-01 |
N0-vs-N1 |
4.110200E-02 |
|
|